Form 4: John Patience Acquires Series A Convertible Preferred Stock in Bio-Rad Laboratories

John Patience, Chairman at Biodesix Inc, reports acquisition of Series A Non-Voting Convertible Preferred Stock, pending stockholder approval for conversion into common stock.

Summary

• John Patience, Chairman of Biodesix Inc, filed a Form 4 detailing changes in beneficial ownership.
• On April 5, 2024, Patience acquired 5,435 shares of Series A Non-Voting Convertible Preferred Stock.
• These shares were issued under securities purchase agreements, contingent on stockholder approval at the 2024 annual meeting to convert the preferred stock into common stock at a rate of 40 common shares per preferred share.
• Post-transaction, Patience beneficially owns 5,435 shares of the Series A Non-Voting Convertible Preferred Stock indirectly through the John Patience Living Trust dated July 23, 1993.
• Patience also owns 217,400 shares of Common Stock.
• The conversion is subject to a limitation preventing Patience from owning more than 19.9% of the outstanding common stock after conversion.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction filing. The acquisition of preferred stock could be seen as a positive sign of confidence, but it's contingent on future events.

Positives

• The acquisition of preferred stock demonstrates John Patience's continued investment in Biodesix Inc.
• The potential conversion of preferred stock into common stock could increase the liquidity of Patience's holdings, subject to stockholder approval and ownership limitations.

Risks

• The conversion of the preferred stock is contingent on stockholder approval, which is not guaranteed.
• The 19.9% ownership limitation could restrict the full conversion of the preferred stock into common stock.

Future Outlook

The future outlook depends on the stockholder approval of the conversion proposal at the 2024 annual meeting, which will determine the extent to which the preferred stock can be converted into common stock.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• Shareholders: Potential dilution if the preferred stock is converted into common stock.
• Company: Potential increase in the number of outstanding common shares if the conversion is approved.

Next Steps

• Stockholder vote on the conversion proposal at the 2024 annual meeting.
• Potential conversion of preferred stock into common stock, subject to approval and ownership limitations.

Key Dates